Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE: 002332)
China
· Delayed Price · Currency is CNY 12.59
-0.19 (-1.49%)
Nov 14, 2024, 3:04 PM CST
Zhejiang Xianju Pharmaceutical Co.,Ltd. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 4,079 | 4,079 | 4,358 | 4,335 | 4,002 | 3,696 | Upgrade
|
| Other Revenue | 43.96 | 43.96 | 21.52 | 22.46 | 16.91 | 12.1 | Upgrade
|
| Revenue | 4,123 | 4,123 | 4,380 | 4,357 | 4,019 | 3,709 | Upgrade
|
| Revenue Growth (YoY) | -0.99% | -5.85% | 0.52% | 8.42% | 8.37% | 2.40% | Upgrade
|
| Cost of Revenue | 1,862 | 1,972 | 1,865 | 1,848 | 1,801 | 1,477 | Upgrade
|
| Gross Profit | 2,261 | 2,152 | 2,515 | 2,509 | 2,218 | 2,232 | Upgrade
|
| Selling, General & Admin | 1,264 | 1,271 | 1,532 | 1,560 | 1,344 | 1,411 | Upgrade
|
| Research & Development | 306.27 | 261 | 266.77 | 243.37 | 208.39 | 204.52 | Upgrade
|
| Other Operating Expenses | 16.47 | 22.04 | 32.92 | 32.73 | 34.43 | 35.04 | Upgrade
|
| Operating Expenses | 1,581 | 1,547 | 1,836 | 1,836 | 1,578 | 1,669 | Upgrade
|
| Operating Income | 680.43 | 604.79 | 678.81 | 672.92 | 640.05 | 562.24 | Upgrade
|
| Interest Expense | -2.18 | -3.37 | -6.29 | -23.1 | -49.23 | -59.84 | Upgrade
|
| Interest & Investment Income | 35.63 | 38.28 | 76.54 | 43.19 | 14.97 | 23.66 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.32 | -9.32 | 11.8 | 17.44 | -25.01 | -1.62 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.18 | -5.53 | -11.25 | -5.26 | -18.64 | -12.92 | Upgrade
|
| EBT Excluding Unusual Items | 704.37 | 624.85 | 749.6 | 705.19 | 562.13 | 511.52 | Upgrade
|
| Gain (Loss) on Sale of Investments | -8.97 | -8.97 | -0 | 0.64 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.5 | -1.48 | 91.62 | 14.51 | -0.74 | -0.02 | Upgrade
|
| Asset Writedown | 3.5 | -0.42 | -0.91 | -1.68 | -1.12 | -13.6 | Upgrade
|
| Other Unusual Items | 27.7 | 27.7 | 31.58 | 11.2 | 32.36 | 29.4 | Upgrade
|
| Pretax Income | 726.1 | 641.68 | 871.89 | 729.87 | 621.25 | 527.3 | Upgrade
|
| Income Tax Expense | 93.24 | 79.56 | 124.49 | 108.6 | 92.25 | 84.82 | Upgrade
|
| Earnings From Continuing Operations | 632.86 | 562.12 | 747.4 | 621.26 | 529 | 442.48 | Upgrade
|
| Minority Interest in Earnings | -11.2 | 0.97 | 2.01 | -1.94 | -24.49 | -32.11 | Upgrade
|
| Net Income | 621.66 | 563.08 | 749.41 | 619.33 | 504.51 | 410.37 | Upgrade
|
| Net Income to Common | 621.66 | 563.08 | 749.41 | 619.33 | 504.51 | 410.37 | Upgrade
|
| Net Income Growth | -10.14% | -24.86% | 21.00% | 22.76% | 22.94% | 36.17% | Upgrade
|
| Shares Outstanding (Basic) | 988 | 988 | 989 | 989 | 917 | 912 | Upgrade
|
| Shares Outstanding (Diluted) | 988 | 988 | 989 | 989 | 917 | 912 | Upgrade
|
| Shares Change (YoY) | -0.16% | -0.13% | 0.00% | 7.84% | 0.59% | -0.14% | Upgrade
|
| EPS (Basic) | 0.63 | 0.57 | 0.76 | 0.63 | 0.55 | 0.45 | Upgrade
|
| EPS (Diluted) | 0.63 | 0.57 | 0.76 | 0.63 | 0.55 | 0.45 | Upgrade
|
| EPS Growth | -10.00% | -24.76% | 21.00% | 13.84% | 22.22% | 36.36% | Upgrade
|
| Free Cash Flow | 72.08 | 360.85 | 326.74 | 409.31 | 671.06 | 257.46 | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.37 | 0.33 | 0.41 | 0.73 | 0.28 | Upgrade
|
| Dividend Per Share | 0.300 | 0.300 | 0.300 | 0.150 | 0.150 | 0.100 | Upgrade
|
| Dividend Growth | 0% | 0% | 100.00% | 0% | 50.00% | 53.85% | Upgrade
|
| Gross Margin | 54.84% | 52.18% | 57.42% | 57.58% | 55.18% | 60.18% | Upgrade
|
| Operating Margin | 16.50% | 14.67% | 15.50% | 15.44% | 15.93% | 15.16% | Upgrade
|
| Profit Margin | 15.08% | 13.66% | 17.11% | 14.21% | 12.55% | 11.07% | Upgrade
|
| Free Cash Flow Margin | 1.75% | 8.75% | 7.46% | 9.39% | 16.70% | 6.94% | Upgrade
|
| EBITDA | 906.17 | 814.13 | 866.26 | 857.11 | 817.16 | 697.36 | Upgrade
|
| EBITDA Margin | 21.98% | 19.74% | 19.78% | 19.67% | 20.33% | 18.80% | Upgrade
|
| D&A For EBITDA | 225.75 | 209.34 | 187.46 | 184.19 | 177.11 | 135.12 | Upgrade
|
| EBIT | 680.43 | 604.79 | 678.81 | 672.92 | 640.05 | 562.24 | Upgrade
|
| EBIT Margin | 16.50% | 14.67% | 15.50% | 15.44% | 15.93% | 15.16% | Upgrade
|
| Effective Tax Rate | 12.84% | 12.40% | 14.28% | 14.88% | 14.85% | 16.09% | Upgrade
|
| Revenue as Reported | 4,123 | 4,123 | 4,380 | 4,357 | 4,019 | 3,709 | Upgrade
|
| Advertising Expenses | - | 685.06 | 991.03 | 1,035 | 864.56 | 811.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.